[HTML][HTML] The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 …
S Pasquali, S Pizzamiglio, N Touati, S Litiere… - European journal of …, 2019 - Elsevier
Background This study was aimed at determining whether patients with high-risk soft tissue
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised …
S Pasquali, S Pizzamiglio, N Touati, S Litiere… - 2019 - pubmed.ncbi.nlm.nih.gov
Background This study was aimed at determining whether patients with high-risk soft tissue
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised …
S Pasquali, S Pizzamiglio, N Touati… - European Journal of …, 2019 - europepmc.org
BACKGROUND: This study was aimed at determining whether patients with high-risk soft
tissue sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
tissue sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
[引用][C] The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 …
S Pasquali, S Pizzamiglio, N Touati, S Litiere… - European Journal of …, 2019 - cir.nii.ac.jp
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue
sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial | CiNii Research …
sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial | CiNii Research …
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised …
S Pasquali, S Pizzamiglio… - European …, 2019 - scholarlypublications …
Background: This study was aimed at determining whether patients with high-risk soft tissue
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised …
S Pasquali, S Pizzamiglio, N Touati, S Litiere… - European Journal of …, 2019 - ejcancer.com
Background This study was aimed at determining whether patients with high-risk soft tissue
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
[引用][C] The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 …
S Pasquali, S Pizzamiglio, N Touati… - EUROPEAN …, 2019 - research.unipd.it
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue
sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial IRIS IRIS …
sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial IRIS IRIS …
The Impact of Chemotherapy on Survival of Patients with Extremity and Trunk Wall Soft Tissue Sarcoma: Revisiting the Results of the EORTC-STBSG 62931 …
S Pasquali, S Pizzamiglio, N Touati, S Litiere… - 2018 - papers.ssrn.com
BACKGROUND: To determine whether patients with high-risk soft tissue sarcoma (STS), as
identified using the nomogram Sarculator, benefitted from adjuvant chemotherapy in the …
identified using the nomogram Sarculator, benefitted from adjuvant chemotherapy in the …
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised …
S Pasquali, S Pizzamiglio, N Touati, S Litiere… - EUROPEAN JOURNAL …, 2019 - air.unimi.it
Background: This study was aimed at determining whether patients with high-risk soft tissue
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …